Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal
Alnylam Pharmaceuticals has forged a discovery collaboration worth up to $1.23bn with cardiovascular disease specialist, Tenaya Therapeutics. Through…
Majority of UK insurance customers want more women in boardrooms – GlobalData
A snapshot survey by the Lloyd’s Market Association (LMA) suggests there are still internal barriers limiting female advancement…